Literature DB >> 19733528

Getting to the root of BRCA1-deficient breast cancer.

Christophe Ginestier1, Suling Liu, Max S Wicha.   

Abstract

Loss of BRCA1 has been shown to expand breast stem cells. In Nature Medicine, Lim et al. (2009) demonstrate that breast tissue from BRCA1 mutation carriers contains expanded luminal progenitor cells, suggesting a broader role for BRCA1 in mammary development.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19733528     DOI： 10.1016/j.stem.2009.08.007

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  16 in total

Review 1.  Targeting breast cancer stem cells.

Authors:  Sean P McDermott; Max S Wicha
Journal:  Mol Oncol       Date:  2010-06-17       Impact factor: 6.603

Review 2.  Oncogenes and tumor suppressor genes.

Authors:  Eva Y H P Lee; William J Muller
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-18       Impact factor: 10.005

3.  Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features.

Authors:  Nadine Tung; Yihong Wang; Laura C Collins; Jennifer Kaplan; Hailun Li; Rebecca Gelman; Amy H Comander; Bridget Gallagher; Katharina Fetten; Karen Krag; Kathryn A Stoeckert; Robert D Legare; Dennis Sgroi; Paula D Ryan; Judy E Garber; Stuart J Schnitt
Journal:  Breast Cancer Res       Date:  2010-02-11       Impact factor: 6.466

4.  Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers.

Authors:  Nadine Tung; Alexander Miron; Stuart J Schnitt; Shiva Gautam; Katharina Fetten; Jennifer Kaplan; Yosuf Yassin; Ayodele Buraimoh; Ji-Young Kim; Attila M Szász; Ruiyang Tian; Zhigang C Wang; Laura C Collins; Jane Brock; Karen Krag; Robert D Legare; Dennis Sgroi; Paula D Ryan; Daniel P Silver; Judy E Garber; Andrea L Richardson
Journal:  Breast Cancer Res       Date:  2010-11-16       Impact factor: 6.466

5.  Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.

Authors:  Christopher A Maxwell; Javier Benítez; Laia Gómez-Baldó; Ana Osorio; Núria Bonifaci; Ricardo Fernández-Ramires; Sylvain V Costes; Elisabet Guinó; Helen Chen; Gareth J R Evans; Pooja Mohan; Isabel Català; Anna Petit; Helena Aguilar; Alberto Villanueva; Alvaro Aytes; Jordi Serra-Musach; Gad Rennert; Flavio Lejbkowicz; Paolo Peterlongo; Siranoush Manoukian; Bernard Peissel; Carla B Ripamonti; Bernardo Bonanni; Alessandra Viel; Anna Allavena; Loris Bernard; Paolo Radice; Eitan Friedman; Bella Kaufman; Yael Laitman; Maya Dubrovsky; Roni Milgrom; Anna Jakubowska; Cezary Cybulski; Bohdan Gorski; Katarzyna Jaworska; Katarzyna Durda; Grzegorz Sukiennicki; Jan Lubiński; Yin Yao Shugart; Susan M Domchek; Richard Letrero; Barbara L Weber; Frans B L Hogervorst; Matti A Rookus; J Margriet Collee; Peter Devilee; Marjolijn J Ligtenberg; Rob B van der Luijt; Cora M Aalfs; Quinten Waisfisz; Juul Wijnen; Cornelis E P van Roozendaal; Douglas F Easton; Susan Peock; Margaret Cook; Clare Oliver; Debra Frost; Patricia Harrington; D Gareth Evans; Fiona Lalloo; Rosalind Eeles; Louise Izatt; Carol Chu; Diana Eccles; Fiona Douglas; Carole Brewer; Heli Nevanlinna; Tuomas Heikkinen; Fergus J Couch; Noralane M Lindor; Xianshu Wang; Andrew K Godwin; Maria A Caligo; Grazia Lombardi; Niklas Loman; Per Karlsson; Hans Ehrencrona; Anna von Wachenfeldt; Rosa Bjork Barkardottir; Ute Hamann; Muhammad U Rashid; Adriana Lasa; Trinidad Caldés; Raquel Andrés; Michael Schmitt; Volker Assmann; Kristen Stevens; Kenneth Offit; João Curado; Hagen Tilgner; Roderic Guigó; Gemma Aiza; Joan Brunet; Joan Castellsagué; Griselda Martrat; Ander Urruticoechea; Ignacio Blanco; Laima Tihomirova; David E Goldgar; Saundra Buys; Esther M John; Alexander Miron; Melissa Southey; Mary B Daly; Rita K Schmutzler; Barbara Wappenschmidt; Alfons Meindl; Norbert Arnold; Helmut Deissler; Raymonda Varon-Mateeva; Christian Sutter; Dieter Niederacher; Evgeny Imyamitov; Olga M Sinilnikova; Dominique Stoppa-Lyonne; Sylvie Mazoyer; Carole Verny-Pierre; Laurent Castera; Antoine de Pauw; Yves-Jean Bignon; Nancy Uhrhammer; Jean-Philippe Peyrat; Philippe Vennin; Sandra Fert Ferrer; Marie-Agnès Collonge-Rame; Isabelle Mortemousque; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Sue Healey; Mary Helen Barcellos-Hoff; Marc Vidal; Stephen B Gruber; Conxi Lázaro; Gabriel Capellá; Lesley McGuffog; Katherine L Nathanson; Antonis C Antoniou; Georgia Chenevix-Trench; Markus C Fleisch; Víctor Moreno; Miguel Angel Pujana
Journal:  PLoS Biol       Date:  2011-11-15       Impact factor: 8.029

6.  TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer.

Authors:  Akop Seksenyan; Asha Kadavallore; Ann E Walts; Brian de la Torre; Dror Berel; Samuel P Strom; Parinaz Aliahmad; Vincent A Funari; Jonathan Kaye
Journal:  BMC Cancer       Date:  2015-01-30       Impact factor: 4.430

7.  Modulatory effects of alpha- and gamma-tocopherols on 4-hydroxyestradiol induced oxidative stresses in MCF-10A breast epithelial cells.

Authors:  Eun-Ju Lee; Seung-Yeon Oh; Mi-Kyung Kim; Sei Hyun Ahn; Byung Ho Son; Mi-Kyung Sung
Journal:  Nutr Res Pract       Date:  2009-09-30       Impact factor: 1.926

8.  A novel BRCA1 mutation in a patient with breast and ovarian cancer: A case report.

Authors:  Josefa Salgado; Marta Santisteban; Cristina Gutiérrez; Carmen Gil; Maitane Robles; Adriana Viedma; Ana Patiño-García
Journal:  Oncol Lett       Date:  2013-07-03       Impact factor: 2.967

Review 9.  BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact?

Authors:  Li Wang; Li-Jun Di
Journal:  Int J Biol Sci       Date:  2014-05-14       Impact factor: 6.580

10.  Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland.

Authors:  Mona Shehata; Andrew Teschendorff; Gemma Sharp; Nikola Novcic; I Alasdair Russell; Stefanie Avril; Michael Prater; Peter Eirew; Carlos Caldas; Christine J Watson; John Stingl
Journal:  Breast Cancer Res       Date:  2012-10-22       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.